BRIEF-Myovant Sciences announces presentation of positive Phase 2 data for Relugolix
May 7 Myovant Sciences Ltd:
* Myovant Sciences announces presentation of positive phase 2 data for Relugolix in women with heavy menstrual bleeding and uterine fibroids at the annual meeting of the American Congress of Obstetricians and Gynecologists
* Says study met its primary endpoint Source text for Eikon: Further company coverage:
GLOBAL MARKETS-Asia stocks edge up on optimism over global growth, dollar soft
TOKYO, June 26 Asian shares edged up on Monday on optimism about global growth, while the dollar was on the defensive as a subdued U.S. inflation outlook capped U.S. bond yields and raised questions about the Federal Reserve's plans to tighten policy.